Cargando…
Generation of a gene-corrected human isogenic iPSC line from an Alzheimer’s disease iPSC line carrying the London mutation in APP (V717I)
We report the genome-editing of an existing iPSC line carrying the London mutation in APP (V717I) into an iPSC line in which the pathogenic mutation was corrected. The resulting isogenic iPSC line maintained pluripotent stem cell morphology, a normal karyotype, expression of pluripotency markers and...
Autores principales: | Hernández, Damián, Schlicht, Stephanie Morgan, Daniszewski, Maciej, Karch, Celeste M., Goate, Alison M., Pébay, Alice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084742/ https://www.ncbi.nlm.nih.gov/pubmed/34088002 http://dx.doi.org/10.1016/j.scr.2021.102373 |
Ejemplares similares
-
Spontaneous ATM Gene Reversion in A-T iPSC to Produce an Isogenic Cell Line
por: Lin, Lucy, et al.
Publicado: (2015) -
Heterozygous LMNA mutation-carrying iPSC lines from three cardiac laminopathy patients
por: Cho, Sangkyun, et al.
Publicado: (2022) -
Banking on iPSC- Is it Doable and is it Worthwhile
por: Solomon, Susan, et al.
Publicado: (2014) -
Roadblocks in the Path of iPSC to the Clinic
por: Garreta, Elena, et al.
Publicado: (2018) -
iPSC Bioprinting: Where are We at?
por: Romanazzo, Sara, et al.
Publicado: (2019)